Using EP50 to forecast treatment adherence in individuals with multiple sclerosis.

Jarmolowicz DP, Reed DD, Bruce AS, Catley D, Lynch S, Goggin K, Lim S-L, Strober L, Glusman M, Norouzinia AN, et al.